ABOUT
Our Investors
The enthusiasm of our investors is a reflection of breakthrough science, hard work and the dedication of our scientists, founders, development team and collaborators. Together we share a vision to transform the lives of individuals with inherited channelopathies, cardiometabolic diseases and cardiomyopathies.
BACKED BY
About our investors
Amplitude Ventures
Amplitude Ventures is a full-stack venture capital firm that builds Canadian companies with world-class management teams and scales them to breakout potential. It applies a proven, evidence-based approach to investing in precision medicine.
Fonds de solidarité FTQ
The Fonds de solidarité FTQ invests to build a better society by channeling the savings of its shareholders into development and risk capital. It offers businesses unsecured financing and strategic support.
Lumira Ventures
Lumira Ventures is a North American healthcare venture capital firm with a two-decade track record of investing in transformative biomedical companies. It is a multi-stage investor partnering with mission driven entrepreneurs to build innovative companies in biotechnology, medical devices and digital health.
Alexandria Venture Investments
Alexandria Venture Investments is Alexandria Real Estate's strategic venture capital platform. Since 1996, it has invested in disruptive life science and technology companies advancing transformative new modalities and platforms.
adMare BioInnovations
adMare BioInnovations uses scientific and commercial expertise, specialized R&D infrastructure and investment capital to build investable companies and robust ecosystems. It helps Canada realize its potential as a global leader in life sciences.
Investissement Québec
Investissement Québec plays an active role in Quebec's economic development by stimulating business innovation, entrepreneurship and business acquisitions. It supports businesses of all sizes with investments and customized financial solutions.
CTI Life Sciences
CTI Life Sciences Fund is a knowledge-driven boutique venture capital firm investing in scalable companies across Canada, the United States and Europe. Its mission is to catalyze emerging science and deliver impactful innovations in biotechnology and healthcare.